Share ownership BioArctic AB

BIOA B

SE0010323311

Biotechnology & Medical Research

Market Closed - Nasdaq Stockholm Other stock markets 10:30:00 05/12/2025 pm IST			5-day change	1st Jan Change
307.60 ^SEK	-3.69%		-0.77%	+54.19%

04/12	Industrial Sector Drives Record Highs on Stockholm Stock Exchange, OMXS30 Index Rises 1.2 Percent	FW
04/12	Bioarctic Executive Sells Shares Worth Approximately SEK 0.3 Million	FW

Share class: BioArctic AB

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	10	1,43,99,996	0	0	44.08 %
Stock B	1	7,39,89,039	3,89,58,857 ( 52.65 %)	0

Major shareholders: BioArctic AB

Name	Equities	%	Valuation
Lars Gunnar Lannfelt 26.52 %	1,96,85,052	26.52 %	616 M kr
Pär Lars Gellerfors 16.36 %	1,21,43,201	16.36 %	380 M kr
Fjärde AP-fonden 7.299 %	54,18,493	7.299 %	170 M kr
Swedbank Robur Fonder AB 4.219 %	31,31,849	4.219 %	98 M kr
RA Capital Management LP 4.2 %	31,17,736	4.2 %	98 M kr
Unionen 3.368 %	25,00,000	3.368 %	78 M kr
Nordea Investment Management AB 3.267 %	24,25,386	3.267 %	76 M kr
Tredje AP-fonden 1.609 %	11,94,212	1.609 %	37 M kr
Indecap Fonder AB 0.6976 %	5,17,858	0.6976 %	16 M kr
Storebrand Asset Management AS 0.2854 %	2,11,904	0.2854 %	7 M kr
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
Lars Gunnar Lannfelt 60 %	86,39,998	60 %	270 M kr
Pär Lars Gellerfors 40 %	57,59,998	40 %	180 M kr

Breakdown by shareholder type

Individuals	62.61%
Institutional	21.94%
Other	3.37%
Unknown	12.08%

Based on 1000 largest holdings

Geographical origin of shareholders

Individuals	62.61%
Sweden	20.66%
United States	4.2%
Norway	0.29%
Netherlands	0.08%
Finland	0.06%
Australia	0.01%
Ireland	0.01%

Based on 1000 largest holdings

BioArctic AB is a Sweden-based company engaged in the biotechnology sector. The Company focuses on the research and development of treatments, which aim at diseases that affect the central nervous system (CNS). Its therapeutic areas encompass neurodegenerative disorders, Alzheimer's disease, Parkinson's disease, complete spinal cord injury, as well as other CNS disorders. The Company owns a technology platform, which develops a range of therapeutic monoclonal antibodies. The Company's pipeline includes product candidates in various clinical phases, such as BAN2401, AE1501, BAN0805, imaging and biochemical biomarkers, BBB-technology and SC0806. The Company also operates through SpineMedical AB.

Employees

122

Sector

Biotechnology & Medical Research

Calendar

18/02 - Q4 2025 Earnings Release

More about the company